Wire Stories
602India Self Testing Kits Market Analysis Report 2022: Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Analysis, COVID-19 Testing – Forecast to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Self Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Analysis, COVID-19...
- 712
“Walk It Like You Talk It”: Mixed Martial Arts World Champion Joanna J?drzejczyk Talks to PUMA’s “Only See Great” Ahead of Sunday’s Rematch
HERZOGENAURACH, Germany–(BUSINESS WIRE)–Three-time MMA world champion and PUMA Ambassador Joanna J?drzejczyk shares her vision of mixed martial arts, as part of...
- 745
“Walk It Like You Talk It”: Mixed Martial Arts World Champion Joanna J?drzejczyk Talks to PUMA’s “Only See Great” Ahead of Sunday’s Rematch
HERZOGENAURACH, Germany–(BUSINESS WIRE)–Three-time MMA world champion and PUMA Ambassador Joanna J?drzejczyk shares her vision of mixed martial arts, as part of...
- 631
NTT Solmare: Season Two of the Obey Me! Anime, Which Is Based on the Hit Game With Over Seven Million Downloads, Will Be Releasing in July!
We are also excited to release the key art ahead of its release! OSAKA, Japan–(BUSINESS WIRE)–#ObeyMe–“Obey Me!” — a mobile game by...
- 643
NTT Solmare: Season Two of the Obey Me! Anime, Which Is Based on the Hit Game With Over Seven Million Downloads, Will Be Releasing in July!
We are also excited to release the key art ahead of its release! OSAKA, Japan–(BUSINESS WIRE)–#ObeyMe–“Obey Me!” — a mobile game by...
- 526
RoboSense Reached Strategic Partnership with WeRide to Promote Large-scale Commercial Application of Autonomous Driving Technologies
Partnership to effectively promote large-scale commercialization and in-depth integration of the industry ecosystem SHENZHEN, China–(BUSINESS WIRE)–#RoboSense–RoboSense, a world-leading provider of Smart LiDAR...
- 599
Zai Lab Announces Breakthrough Therapy Designations Granted for Repotrectinib in China
— Breakthrough Therapy Designations granted for ROS1-positive non-small cell lung cancer (NSCLC) patients pretreated with one prior line of ROS1 tyrosine kinase...
- 674
BeiGene Highlights Growing Portfolio and Pipeline Targeting Hematologic Malignancies at European Hematology Association 2022 Congress
Clinical data and patient-reported outcomes across extensive clinical development program for zanubrutinib (BRUKINSA®) reinforce its potential across B-cell malignancies Long-term safety and...
- 553
China NMPA Approves Tislelizumab for Recurrent or Metastatic Nasopharyngeal Cancer
Tislelizumab is now approved in nine indications in China CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi—BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE:...
- 533
ChromaDex Signs Sinopharm Xingsha Agreement to Accelerate Cross-Border Sales of Tru Niagen® into Mainland China
Under the distribution agreement, all cross-border operations in the region will be transitioned to Sinopharm, with Sinopharm investments to amplify Tru Niagen®...
